tiprankstipranks
Strides Pharma Science Ltd (IN:STAR)
:STAR
India Market

Strides Pharma Science Ltd (STAR) Income Statement

3 Followers

Strides Pharma Science Ltd Income Statement

Last quarter (Q2 2026), Strides Pharma Science Ltd's total revenue was ₹12.21B, an increase of 4.62% from the same quarter last year. In Q2, Strides Pharma Science Ltd's net income was ₹1.28B. See Strides Pharma Science Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 44.75B₹ 38.28B₹ 36.68B₹ 30.59B₹ 32.80B
Gross Profit
₹ 11.83B₹ 8.51B₹ 8.05B₹ 4.11B₹ 9.59B
Operating Expenses
₹ 6.65B₹ 5.49B₹ 6.82B₹ 6.63B₹ 6.44B
Depreciation and Amortization
₹ 1.92B₹ 2.13B₹ 2.43B₹ 2.30B₹ 2.02B
EBITDA
₹ 7.10B₹ 5.15B₹ 3.66B₹ -214.95M₹ 5.17B
Operating Income
₹ 5.18B₹ 3.02B₹ 1.24B₹ -2.52B₹ 3.15B
Other Income/Expenses
₹ -313.81M₹ -4.17B₹ -4.10B₹ -4.01B₹ -395.09M
Pretax Income
₹ 4.87B₹ -1.15B₹ -2.86B₹ -6.53B₹ 2.75B
Net Income
₹ 4.05B₹ -1.20B₹ -2.21B₹ -4.60B₹ 2.55B
Per Share Metrics
Basic EPS
₹ 44.05₹ -13.21₹ -24.56₹ -51.28₹ 28.40
Diluted EPS
₹ 44.05₹ -13.21₹ -24.56₹ -51.28₹ 28.37
Weighted Average Shares Outstanding
92.01M 91.00M 90.08M 89.75M 89.61M
Weighted Average Shares Outstanding (Diluted)
92.02M 91.13M 90.09M 89.75M 89.71M
Currency in INR

Strides Pharma Science Ltd Earnings and Revenue History